baber/WOPTO huggingface dataset:
Patent FI-963340-A0 (FI)
Inventor: NODA ISAO
IPC: A61F13/551
Filed: 1996-08-27
Abstract: The present invention relates to a process for preparing biodegradable fibrils from one or more biodegradable homopolymeric or copolymeric resins, the process comprising: a) forming a liquid resin mixture by solvating the biodegradable resin or resins; and b) introducing the liquid resin mixture to a nonsolvent while the nonsolvent is stirred. The invention further relates to the biodegradable fibrils prepared using the processes of the present invention. The invention further relates to nonwoven fabrics comprising the biodegradable fibrils of the present invention. The invention further relates to a disposable absorbent article comprising a water-permeable topsheet, an absorbent core, and a water-impermeable backsheet, wherein the topsheet comprises a nonwoven substrate comprising biodegradable fibrils of the present invention. The present invention further relates to textiles comprising the biodegradable nonwoven fabrics of the present invention.
Patent FI-964285-A0 (FI)
Inventor: DURR MANFRED
IPC: A61K31/425
Filed: 1996-10-24
Abstract: This invention relates to a pharmaceutical composition comprising as active principle, docetaxel or a taxoid derived from docetaxel, one or more unsaturated phospholipids and a small amount of one or more negative phospholipids, allow the active principle to be formulated in high concentration and are suitable for administration by injection.
Patent FI-973600-A0 (FI)
Inventor: HUTTUNEN ARI
IPC: H04W4/029
Filed: 1997-09-04
Abstract: The present invention relates to a method and an arrangement for finding information in a communications system comprising a circuit switched network, a packet switched network and a link therebetween. A user related location information is obtained by the circuit switched network and the packet switched network is subsequently utilized using said location information for finding the desired information. The invention relates further to a mobile station to be used in accordance with the invention.
Patent IL-63097-A0 (IL)
Title: A process and extractant for removing fluorine compounds from aqueous phosphoric acid
IPC: C01B25/237
Filed: 1981-06-15
Abstract: A process for removing fluorine compounds from aqueous phosphoric acid containing the same, comprises contacting the phosphoric acid with a water insoluble extractant comprising phosphoric acid and an oil soluble amine. The amine is substantially water insoluble both in free and in salt form and the extractant is substantially free of fluorine, sulfate and metal impurities. An extractant for use in the above process comprises an oil soluble amine which is substantially water insoluble both in free and in salt form, and a phosphoric acid.
Patent IL-68123-A0 (IL)
Title: Pharmaceutically active copolymers,process for their preparation and pharmaceutical compositions containing them
IPC: C08F8/44
Filed: 1983-03-14
Abstract: The invention relates to new, pharmaceutically active copolymers with heparin-like activity, pharmaceutically acceptable salts thereof and a process for their preparation. The new copolymers comprising the units of the general formula /I/derived from /meth/acrylic acid or an ester thereof /X stands for hydrogen or methyl and Y is hydrogen/, units of the formula /III/optionally units of the general formula /II//Z' is hydrogen/, and chain terminating units, formed from the units of the formulae /I/, /III/ and optionally /II/ under the conditions of copolymerization, in a statistical arrangement, and the pharmaceutically acceptable salts thereof, which contain, in addition to the above chain-members, units of the general formulae /IV/ and/or /V//X has the same meaning as defined above, and A is a cation/ satisfactorily replace the organogenic heparin, or give a synergistic combination with that.
Patent IL-73598-A0 (IL)
Title: Fluid control device particularly useful in liquid transfusion apparatus
IPC: A61M5/175
Filed: 1984-11-23
Abstract: A fluid control device for a liquid transfusion line comprises an inlet connector (4) and an outlet connector (8), and a flexible conduit (10) defining two, three or more passageways (11, 12, 13) extending in parallel between them to provide a plurality of parallel paths for the flow of the fluid. The device further includes a restrictor (16, 18) in one or more of the passageways (11, 12, 13) restricting the flow according to a fixed predetermined rate lowerthan that of unrestricted passageway (12), and a manual control member (14) for selectively closing the passageways (11, 12, 13) to produce a flow of the fluid from the inlet connector (4) to the outlet connector (8) according to a preselected fixed rate.
Patent IL-79626-A0 (IL)
Title: Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues
IPC: A61K38/00
Filed: 1986-08-05
Abstract: Polypeptide derivatives containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues are of the formula:wherein, for example in a preferred embodiment R is t-butyloxycarbonyl, m and n are each 0 or 1, their sum being at least 1; R is cyclohexylmethyl; R<sup>2</sup> is 2-methylpropyl, 2-methyl-2--propenyl, benzyl, 4-chlorobenzyl, 3-chlorobenzyl, 4-methylbenzyl, 4-methoxybenzyl, 3,4-dichlorobenzyl, 2-chlorobenzyl or cyclohexylmethyl; R<sup>3</sup> is hydrogen; R<sup>4</sup> is hydrogen, methyl, 4-aminobutyl, 2-carboxyethyl, 3-(ethoxycarbonyl)propyl or 3-(benzyloxycarbonyl)propyl; W is phenylalanyl, W<sup>1</sup> is histidyl and W<sup>2</sup> is lysyl.These compounds are useful for inhibiting the angiotensinogen cleaving action of the enzyme renin having particular utility in the treatment of hypertension.
Patent IL-91515-A0 (IL)
Title: System for cooperatively reassigning duties in a multiple controller environment
IPC: H04W84/08
Filed: 1989-09-04
Abstract: A radio communication system having the capability of providing acknowledgement messages to incoming messages while compensating for failed components that have the duty of acknowledging messages or redistributing the acknowledgment duties evenly among the components when there is a change in acknowledgment responsibilities. There is also disclosed a method for cooperatively reassigning certain tasks to certain users within a communication system.
Patent IL-100386-A0 (IL)
Title: Cell free marek's disease virus vaccine
IPC: C12N7/08
Filed: 1991-12-16
Abstract: The present invention is concerned with a vaccine for the protection of poultry against Marek's Disease. The cell free vaccine of the invention facilitates the handling of the vaccine and reduces the chance of physical abuse. The invention also relates to bivalent or polyvalent vaccines comprising in addition other viruses of the Marek's Disease virus group, i.e. HVT.
Patent IL-127668-A0 (IL)
Title: Indole derivatives for the treatment of osteoporosis
IPC: C07D413/12
Filed: 1997-07-03
Abstract: A compound of formula (I): or a salt thereof, or a solvate thereof, wherein Ra represents a group R<SUB>5 </SUB>which is hydrogen, alkyl or optionally substituted aryl and Rb represents a moiety of formula (a): wherein X represents a hydroxy or an alkoxy group wherein the alkyl group may be substitued or unsubstituted or X represents a group NR<SUB>s</SUB>R<SUB>t </SUB>wherein R<SUB>s </SUB>and R<SUB>t </SUB>each independently represent hydrogen, alkyl, substituted alkyl, optionally substituted alkenyl, optionally substituted aryl, optionally substituted arylalkyl, an optionally substituted heterocyclic group or an optionally substituted heterocyclylalkyl group, or R<SUB>s </SUB>and R<SUB>t </SUB>together with the nitrogen to which they are attached form a heterocyclic group; R<SUB>1 </SUB>represents an alkyl or a substituted or unsubstituted aryl group; and R<SUB>2</SUB>, R<SUB>3 </SUB>and R<SUB>4 </SUB>each independently represent hydrogen, alkyl, aryl or substituted aryl; R<SUB>6 </SUB>and R<SUB>7 </SUB>each independently represent hydrogen, hydroxy, amino, alkoxy, optionally substituted aryloxy, optionally substituted benzyloxy, alkylamino, dialkylamino, halo, trifluoromethyl, trifluoromethoxy, nitro, alkyl, carboxy, carbalkoxy, carbamoyl, alkylcarbamoyl, or R<SUB>6 </SUB>and R<SUB>7 </SUB>together represent methylenedioxy, carbonyldioxy or carbonyldiamino; and R<SUB>8 </SUB>represents hydrogen, hydroxy, alkynoyl, alkyl, aminoalkyl, hydroxyalkyl, carboxyalky, carbalkoxyalkyl, carbamoyl or aminosulphonyl; a process for preparing such a compound, a pharmaceutical composition containing such a compound and the use of such a compound in medicine.
Patent IL-141091-A0 (IL)
Title: Substituted cinnamic acids and cinnamic acids esters
IPC: C07C63/74
Filed: 1999-08-09
Abstract: The invention relates to substituted cinnamic acids and cinnamic acid esters of formula (I), wherein X represents F, Cl or J and R1 and R2 are the same or different and represent hydrogen, an optionally substituted C1-C10-alkyl radical or an optionally substituted benzyl radical. Substituted indanone carboxylic acid esters are produced using said substituted cinnamic acid and cinnamic acid ester in a technically simple and non-dangerous manner as far as safety is concerned.
Patent IL-158582-A0 (IL)
Title: Handheld apparatus and method for transdermal drug delivery and analyte extraction
IPC: A61N1/30
Filed: 2002-04-22
Abstract: A device (500,600) is provided for treating skin (22) on the body of a subject. The device includes a plurality of receiving electrodes (514,610), which are adapted to be placed in contact with the skin so as to provide electrical contact with the skin, a driving electrode (512,650), which is adapted to be passed across the receiving electrodes so as to create electrical contact with a first one of the receiving electrodes prior to creating electrical contact with a second one of the receiving electrodes. The device additionally includes a power source (52,114,154,172,192,212,222), which is adapted to drive the driving electrode to apply a first current to the first receiving electrode (612) when the driving electrode is in electrical contact with the first receiving electrode, and to apply a second current to the second receiving electrode (613) when the driving electrode is in electrical contact with the second receiving electrode. <IMAGE>
Patent IL-164776-A0 (IL)
Title: Sampling device for liquid samples
IPC: G01N27/28
Filed: 2003-05-02
Abstract: A device for sampling liquid samples is provided comprising a capillary-active channel, a sampling site, and a determination site. The capillary-active channel is configured for transporting a sample from the sampling site to the determination site. The capillary-active channel is substantially formed by a carrier, a cover and an intermediate layer located between the carrier and cover. The carrier protrudes beyond the cover in the area of the sampling site. The intermediate layer is displaced towards the back in the direction of the determination site in the area of the sampling site so that the carrier as well as the cover protrude beyond the intermediate layer. The device allows sample to be applied from above onto the exposed area of the carrier in the area of the sampling site and also allows sample to be applied from the side.
Patent IL-179549-A0 (IL)
Title: Injection device
IPC: A61M5/32
Filed: 2006-11-23
Abstract: An injection device (210) is described. A housing (212) receives a syringe and includes a return spring (226) for biasing the syringe from an extended position in which its needle (218) extends from the housing (212) to a retracted position in which the it does not. A drive spring (230) acts on a first drive element (232) and a second drive element (234) acts upon the syringe to advance it from its retracted position to its extended position and discharge its contents through the needle. The first drive element (232) is capable of movement relative to the second (234) once a nominal decoupling position has been reached. A release mechanism is activated when the first drive element (234) is further advanced to a nominal release position, to release the syringe (214) from the action of the drive spring (230), whereupon the return spring (226) restores the syringe (214) to its retracted position. A locking mechanism (337, 375) confines the returned syringe in its retracted position.
Patent IL-180402-A0 (IL)
Title: Methods and systems for securing access to private networks
Filed: 2006-12-28
Abstract: A method for routing packages from an endpoint (110) to a gateway (120) includes receiving a filtering table from a client application. An outbound packet is intercepted and transmitted to the client application, responsive to the filtering table. The client application transmits the outbound packet to a gateway responsive to an application of a policy to the outbound packet and a routing table. Information about the outbound packet is also transmitted to the client application. The outbound packet is also transmitted to a port monitored by the client application. The method further includes, by the application: authentication of the endpoint to the gateway; encrypting the outbound packet; and establishing a secure sockets layer (SSL) tunnel to the gateway (120). The client application resides on a gateway computing device (120), on a client computing device (110), or on a peripheral device.
Patent IL-185014-A0 (IL)
Title: Imidazopyridazine compounds
Filed: 2007-08-02
Abstract: The present invention relates to novel substituted imidazo[1,2-b]pyridazine compounds of Formula (I): pharmaceutical compositions thereof, and the use such compounds as corticotropin releasing factor 1 (CRF1) receptor antagonists in the treatment of psychiatric disorders and neurological diseases.
Patent IL-189977-A0 (IL)
Title: Turbine flowmeter
Filed: 2008-03-06
Abstract: The invention relates to a turbine flowmeter for measuring the consumption of fluids, particularly water. The turbine flowmeter comprises a housing (1) with an inflow (2), and outflow (3) and a flow channel (4). The turbine flowmeter also comprises a measuring unit (5) for measuring and indicating the consumption. A turbine (10) with a hub (11) and a number of radial vanes (12.1, 12.2) is located inside the channel (4). A holding insert (20) is also located inside the channel (4) and is comprised of a water guide cross (20.1) and of an insert base body (20.2). The water guide cross (20.1) comprises a hub (21), radial struts (22) extending from the hub (21) to the wall of the channel (4), a nozzle body (23), which surrounds the front (14) of the turbine (10), however, a gap (17) remains through which the fluid flows, and comprises a central opening (24) in the nozzle body (23). The vanes (12.1. 12.2) of the turbine (10) are positioned near the nozzle body (23). A nozzle ring (16) connects the vanes (12.1, 12.2) and extends over the outer contour of the nozzle body (23) so that a nozzle gap (18) remains between the nozzle ring (16) and the nozzle body (23). This nozzle gap (18) communicates with the gap (17) between the nozzle body (23) and the front (14) of the turbine (10). The gap (17) and the nozzle gap (18) guide the fluid so that the turbine starts running even with the smallest flow of fluid and, even during a maximum rate of flow, keeps its position behind the water guide cross (20.1) without requiring any bearing.
Patent RO-132105-A0 (RO)
Title: Internal-combustion and internal-cooling engine
Inventor: BANCHEŞ EUGEN
IPC: F02B75/32
Filed: 2017-03-30
Abstract: The invention relates to a compression-ignition internal-combustion and internal-cooling engine meant to actuate machines, equipments, installations, transportation means and electric generator sets. According to the invention, the engine consists of a mechanism (A) of translation-rotation conversion, a distribution mechanism (B) and a combustion chamber unit (C), providing the conditions necessary to perform the working cycle with internal-combustion and internal-cooling, the mechanism (A) of translation-rotation conversion providing the efficient conversion of the piston reciprocating translation movement into continuous rotation movement which, in another embodiment, may be made with two or four pistons, and the distribution mechanism (B) providing the variable gas distribution in the cylinder by a controlled actuation of both the opening of some concentric ring-like valves for intake and discharge and the opening of the communication between the cylinder and the combustion chamber unit (C) at constant volume, the combustion chamber unit (C) providing the conditions for performing the fuel injection and its combustion controlled, in stages, initially at constant volume and further, if necessary, at constant pressure, in the cylinder.
Patent RO-132600-A0 (RO)
Title: Method and equipment for fluid pressure regulation
Inventor: STAICU CONSTANTIN DAN DORIN
IPC: G05D7/06
Filed: 2017-11-22
Abstract: The invention relates to a method and an equipment for regulation of a fluid pressure within pipe networks which convey variable flow-rates. According to the invention, the equipment comprises a hydraulic machine (7) which supplies with fluid the said pipe network, where the maximum flow-rate (Q) of the hydraulic machine (7) is set to be higher than or equal to the sum of the flow-rates needed by the network (Q), comprising a pressure transducer (1) mounted in each network point where a permanent minimum pressure value (Mp) or an accidental minimum pressure value (Ma) is recorded, said pressure transducers (1) transmitting these values, by means of a data acquisition system (2), using a communication system (3), to a receiver (4) which is in connection with a programmable automaton (5) which analyzes the pressure within the network, as well as within the intake pipe, by means of another pressure transducer (8), and controls a frequency variator (6) that adjust the rotary speed (n) of the hydraulic machine (7), in order to ensure the network the required pressure (H), according to its hydraulic characteristic, and to prevent cavitation, in the case of liquids.
Patent RO-135807-A0 (RO)
Title: Process for making a product based on hydroxyapatite and biogenic biphase calcium phosphate for reconstruction of bone defects
Inventor: MICULESCU FLORIN
IPC: A61L27/32
Filed: 2021-05-17
Abstract: The invention relates to a process for making a product based on hydroxyapatite and biogenic biphasic tricalcium phosphorus for the reconstruction of bone defects . According to the invention, the process includes a preliminary stage of thermal dissociation of calcium carbonate as dolomitic marble and sea shells in an electric oven at a temperature of 1300°C for 6 hours in air, the resulting Ca oxide being hydrated with distilled water and the resulting solution being treated with 85% phosphoric acid pipetted at a rate of 1 ml/min. starting from the calculation of the quantities determined according to the stoichiometric reactions, the amount of phosphoric acid being increased to 110...130% x the calculated stoichiometric amount, the solution is stirred for 2 hours at a temperature of 25°C, the resulting product is dried by final heat treatment at 120°C for 24 hours, after which it is ground in an aggregate ball mill for 2 hours, it is sorted granulometrically by vibration on successive sieves with mesh sizes ranging between 100...20 μ m, the obtained powders are mixed with bundles of hemp fibers cut to lengths of 10...50 mm and braided/twisted as a bundle with a thickness of 0.5…1.5 mm and then soaked in a solution of starch and bioglass 0.1...2% of the starch mass, made by mixing 1/5...1/20 volumetric parts of starch and bioglass/distilled water in a thermostated bath at 70...80°C, the ratio ceramic powder/hemp fiber mass being predetermined according to the degree of porosity ranging between 10...50%, the resulting mixture is compacted by cold isostatic pressing in moulds with a diameter of 10...50 mm with compressive forces between 10...25 MPa, followed by sintering at 900...1300°C for 1...12 hours in air, the porosity of the final product resulting after complete combustion, and the dimensional reduction of the cylindrical samples and of the resulting channels ranging between 20...35%.
Patent MA-27980-A1 (MA)
Title: Nouvelle composition
Inventor: HOKE JOHN FRANCIS
IPC: A61K9/24
Filed: 2006-02-07
Abstract: Composition pour la libération d'une base faible pendant une période de temps prolongée Une forme posologique orale comprenant une première composition et une seconde composition, chaque composition comprenant une base faible pharmaceutiquement acceptable, notamment le Composé A ou un de ses sels ou produits de solvatation pharmaceutiquement acceptables ("le médicament"), et un support pharmaceutiquement acceptable à cette fin, dans laquelle les première et seconde compositions sont conçues pour libérer le médicament à des vitesses de libération différentes par administration de telle sorte que la vitesse de libération du médicament par la forme posologique soit substantiellement indépendante du pH ; un procédé pour la préparation d'une telle forme posologique et l'utilisation d'une telle forme posologique en médecine.
Patent MA-20150192-A1 (MA)
Title: لوحة ذكية م وجه لتطبيقات التعليمية
Inventor: MOHSINE BOUYA
IPC: G09B7/07
Filed: 2013-11-26
Abstract: يقدم هذا الإختراع لوحة ذكية يكمن إستعمالها من طرف المدرسين و الطلبة تمكن من تسهيل المهام التنظيمية و التواصل و تعتمد هذه اللوحة على مجموعة من الوحدات البرمجية
Patent MA-37664-A1 (MA)
Title: Formulation pour implant contenant de la rispéridone et/ou de la palipéridone
Inventor: GUTIERRO ADURIZ IBON
IPC: A61K47/34
Filed: 2013-05-31
Abstract: Cette invention concerne une composition retard injectable par voie intramusculaire adaptée à former in situ un implant solide dans le corps. La composition comprend de la rispéridone et/ou de la palipéridone (médicaments) et/ou l'un quelconque de leurs sels pharmaceutiques acceptables, quelle que soit leur combinaison, un copolymère biocompatible à base d'acide lactique et d'acide glycolique dont le rapport monomère acide lactique sur acide glycolique se situe dans la plage 50:50, et du dmso pour solvant. La composition libère la rispéridone et/ou de la palipéridone immédiatement et en continu pendant au moins 4 semaines, son profil pharmacocinétique in vivo permettant que la formulation soit administrée toutes les 4 semaines ou sur des périodes plus longues.
Patent MA-20150403-A1 (MA)
Title: Composition lubrifiante a base d'ether de polyglycerol
Inventor: IOVINE RAPHAELE
IPC: C10N40/25
Filed: 2013-12-20
Abstract: La présente invention concerne une composition lubrifiante comprenant au moins un éther de polyglycérol ramifié, et plus particulièrement au moins un éther de polyglycérol ramifié et au moins un dispersant.
Patent MA-38267-A1 (MA)
Inventor: JONES NICHOLAS
IPC: E04C2/26
Filed: 2013-12-12
Abstract: يتعلق الاختراع الحالي بلوحة للاستخدام في تشييد المباني تشتمل على لوح جصي له اثنين من الأوجه المتقابلة, و صفيحة أساسها البوليمر يتم توفيرها على أحد الأوجه. و يقع وزن اللوحة لكل وحدة مساحة في مدى يتراوح بين 13.5 إلى 17.5 كجم/م2, و يقع سمك اللوحة في مدى يتراوح بين 11 إلى 25 مم
Patent MA-38954-A1 (MA)
Title: Procede et equipement de banalisation des produits pharmaceutiques perimes et de soins veterinaires perimes
Inventor: AZZI MOHAMMED
IPC: B09B3/00
Filed: 2016-04-07
Abstract: Le procédé et équipement de banalisation des produits pharmaceutiques périmés, des produits de soin vétérinaires périmés ainsi que leurs emballages et les déchets qui leurs sont associés, consiste en une opération de tri, suivie d'un broyage mécanique (3). L'ensemble du broyat est traité par la conjugaison d'action mécanique et chimique dans un réacteur rotatif innovant (5) spécialement conçu à cet effet. L'effet chimique permet de conjuguer l'action du ph et du potentiel d'oxydation pour faciliter la libération de la matière active et sa banalisation. L'effet mécanique dû à l'action de rotation du réacteur, permet de réaliser la banalisation de l'ensemble du broyat (principe actifet matière d'emballage). Après analyse et vérification de la qualité du traitement du mélange hétérogène, les phases liquides et solides sont séparées et acheminés vers le réseau conventionnel d'élimination.